[The role of radiotherapy in the treatment of malignant lymphoma].
Eighty-four patients with malignant lymphoma in N.I.R.S., whose five-year survival was evaluated, were divided into two groups. The first one was treated mainly with irradiation between 1961 and 1972 (n = 36) and the second one mainly with anticancer drugs thereafter (n = 48). The survival of the second group was significantly superior to the first one: 60% vs 20% in the five-year survival rate of Hodgkin lymphoma (HL) and 40% vs 20% in non-Hodgkin lymphoma (NHL). These results were due to the systemic application of chemotherapy in the second group. On the other hand, 40% of the patients with NHL in the head and neck at stages I + II and who received radiotherapy alone survived. Through a detailed analysis of these data, the role of radiotherapy in the treatment of malignant lymphoma was discussed.